Company Overview and News

 
Iron Mountain: A Stock For Safe Keeping

2018-04-10 seekingalpha
IRM has roughly 85 million sq. ft. of space in 1,400 facilities across 46 countries, to assist clients in reducing costs and mitigating risks associated with storage of their assets.
Upvote Downvote

 
This 6.2% Yielding Industry-Dominating Blue Chip Is 28% Undervalued

2017-12-16 seekingalpha
Data and Storage REITs have been hot over the past year, and Iron Mountain is no exception.
Upvote Downvote

 
Iron Mountain (IRM) Q3 FFO Misses Estimates, Revenues Beat

2017-10-25 zacks
Iron Mountain Inc. (IRM - Free Report) reported third-quarter 2017 normalized funds from operations (FFO) of 55 cents per share that missed the Zacks Consensus Estimate of 56 cents but increased 10% year over year.
Upvote Downvote

 
Iron Mountain (IRM) to Report Q3 Earnings: What's in Store?

2017-10-23 zacks
Iron Mountain Inc. (IRM - Free Report) is set to release third-quarter 2017 results on Oct 24.
Upvote Downvote

 
Earnings Review and Free Research Report: Iron Mountain’s Revenue Grew 7.5%; Adjusted FFO Soared 39.6%

2017-08-14 accesswire
LONDON, UK / ACCESSWIRE / August 14, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Iron Mountain Inc. (NYSE: IRM), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=IRM, following the Company's release of its second quarter fiscal 2017 earnings results on July 28, 2017. The storage and information management Company surpassed Wall Street's estimates.
Upvote Downvote

 
Iron Mountain (IRM) Q2 FFO Tops Estimates, Revenues Lag

2017-07-28 zacks
Iron Mountain Inc. (IRM - Free Report) reported second-quarter 2017 normalized funds from operations (FFO) of 55 cents per share that surpassed the Zacks Consensus Estimate of 52 cents and increased 14.6% year over year.
Upvote Downvote

 
Iron Mountain (IRM) Q1 FFO Misses Estimates, Revenues Top

2017-04-27 zacks
Iron Mountain Inc. (IRM - Free Report) reported first-quarter 2017 normalized funds from operations (FFO) of 48 cents per share that missed the Zacks Consensus Estimate of 51 cents and decreased 7.4% year over year.
Upvote Downvote

 
Iron Mountain (IRM) Q4 FFO Beats, Initiates 2017 Guidance

2017-02-23 zacks
Iron Mountain Inc. (IRM - Free Report) reported fourth-quarter 2016 normalized funds from operations (FFO) of 50 cents per share that beat the Zacks Consensus Estimate of 45 cents but fell 12.3% year over year.
Upvote Downvote

 
Iron Mountain (IRM) Lags Q3 FFO Estimates, Cuts Guidance

2016-11-01 zacks
Iron Mountain Inc. (IRM - Analyst Report) reported third-quarter 2016 normalized funds from operations (FFO) of 44 cents per share that came below the Zacks Consensus Estimate of 58 cents and fell 20% year over year.
Upvote Downvote

 
Brink’s appoints new CEO

2016-09-18 seekingalpha
Brink’s Company (NYSE:BCO) announces that its board of directors has appointed Douglas Pertz as CEO and as a director of the company, effective immediately.
Upvote Downvote

 
Iron Mountain (IRM) Q2 FFO Lags Estimates, Revenues Beat

2016-08-04 zacks
Iron Mountain Inc. (IRM - Analyst Report) reported second-quarter 2016 normalized funds from operations (FFO) of 47 cents per share that came below the Zacks Consensus Estimate of 53 cents and fell 4.1% year over year.
Upvote Downvote

 
Iron Mountain (IRM) to Post Q2 Earnings: What to Expect?

2016-08-01 zacks
Iron Mountain Inc. (IRM - Analyst Report) , a leading provider of data protection and information management services, is set to release its second-quarter 2016 results on Aug 4. Last quarter, the company delivered a positive earnings surprise of 6.25%. The company has posted an average negative earnings surprise of 1.95% over the past four quarters.
Upvote Downvote

 
The Brink's Company's (BCO) CEO Douglas Pertz on Q2 2016 Results - Earnings Call Transcript

2016-07-28 seekingalpha
Welcome to The Brink's Company's Second Quarter 2016 Earnings Call. Brink's issued a press release on second quarter results this morning. The Company also filed an 8-K that includes the release and the slides that will be used in today's call.
Upvote Downvote

 
Brink's New CEO Has Skin In The Game

2016-06-16 seekingalpha
Brinks looks primed for a strong turnaround attempt or an outright sale to a strategic buyer.
Upvote Downvote

 
BRIEF-Iron Mountain says CMA completes phase 2 review

2016-06-16 reuters
* United Kingdom's competition and markets authority completed its phase 2 review of Iron Mountain's acquisition of Recall Holdings Limited
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

11h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...